SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-021614
Filing Date
2020-09-25
Accepted
2020-09-25 17:27:39
Documents
11
Period of Report
2020-09-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10015485_8k.htm 8-K 22006
2 EXHIBIT 99.1 brhc10015485_ex99-1.htm EX-99.1 20754
3 EXHIBIT 99.2 brhc10015485_ex99-2.htm EX-99.2 7991
4 EXHIBIT 99.3 brhc10015485_ex99-3.htm EX-99.3 31542
5 brhc10015485_ex99-2slide1.jpg GRAPHIC 94968
6 brhc10015485_ex99-2slide2.jpg GRAPHIC 83203
7 brhc10015485_ex99-2slide3.jpg GRAPHIC 144786
8 brhc10015485_ex99-2slide4.jpg GRAPHIC 108191
9 brhc10015485_ex99-2slide5.jpg GRAPHIC 58945
10 image0.jpg GRAPHIC 12481
11 image00001.jpg GRAPHIC 7963
  Complete submission text file 0001140361-20-021614.txt   787481
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 201201106
SIC: 2834 Pharmaceutical Preparations